Goldman Sachs’s Insmed INSM Stock Holding History

Goldman Sachs’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58,500	Closed	-$10.2M	–	6735
2025 Q4	$10.2M	Sell	58,500 -71,500	-55%	-$13M	﹤0.01%	3084
2025 Q3	$18.7M	Buy	130,000 +30,000	+30%	+$3.68M	﹤0.01%	2328
2025 Q2	$10.1M	Buy	+100,000	New	+$7.65M	﹤0.01%	2750
2025 Q1	–	Sell	-35,300	Closed	-$2.44M	–	6232
2024 Q4	$2.44M	Buy	+35,300	New	+$2.54M	﹤0.01%	4113
2016 Q2	–	Sell	-59,500	Closed	-$754K	–	7128
2016 Q1	$754K	Sell	59,500 -500	-0.8%	-$6.57K	﹤0.01%	4335
2015 Q4	$1.09M	Hold	60,000	–	–	﹤0.01%	4214
2015 Q3	$1.11M	Buy	60,000 +10,000	+20%	+$250K	﹤0.01%	4367
2015 Q2	$1.22M	Buy	+50,000	New	+$1.14M	﹤0.01%	4348
2015 Q1	–	Sell	-49,600	Closed	-$767K	–	7179
2014 Q4	$767K	Buy	+49,600	New	+$704K	﹤0.01%	4863
2014 Q3	–	Sell	-24,400	Closed	-$488K	–	7178
2014 Q2	$488K	Sell	24,400 -757,200	-97%	-$11.2M	﹤0.01%	5344
2014 Q1	$14.9M	Buy	+781,600	New	+$14.9M	﹤0.01%	2012

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs's INSM Position: Q1 2026 in Review

Goldman Sachs reduced its Insmed (INSM) stake by 24% in Q1 2026, selling an estimated $46.5M and leaving 942,646 shares worth $154M. The position accounts for 0.02% of the portfolio, ranked #808.

Goldman Sachs first reported a position in INSM in Q3 2013 and has held it in 51 quarters since. The position peaked at $217M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Goldman Sachs held 942,646 shares of Insmed worth $154M as of Q1 2026.
Goldman Sachs sold 302,267 Insmed shares in Q1 2026, an estimated $46.5M.
Insmed made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #808 holding.
Goldman Sachs first reported a position in Insmed in Q3 2013 and has held it in 51 quarters since.
Goldman Sachs's Insmed position peaked at $217M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.